Latest News by Industry
North Providence, RI, and Golden, CO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCQB: RLBD) announced today that it has signed the definitive agreement for the acquisition of substantially all the assets of Boulder Botanical & Biosciences Laboratories, Inc. ( Boulder Botanical ), a manufacturer of white-label and private-label wellness and sports medicine herbal supplements and CBD products, from Frankens Investment Fund, LLC, which had acquired Boulder Botanical in April 2022. The acquisition will include Boulder Botanical’s brands for human and pet markets, IP, and distribution at the 27,000 sq. ft. R&D and production facility in Golden, Colorado. The value of the transaction is $12 million, with a $1 million operating capital commitment. Boulder Botanical will retain its name and operate as a division of Real Brands.
Thom Kidrin, President & CEO of Real Brands Inc., stated, “Boulder Botanical has had an excellent reputation for creating quality sports medicine, health and wellness herbal supplements and cannabinoid formulations and its white-label manufacturing services exceeding industry standards. We expect to build upon that solid foundation. Boulder Botanical’s existing national distribution network serving CVS, Target, Costco, and other retailers, combined with Real Brands’ expertise in online sales and the metaverse, enables ready access to millions of existing customers and millions more potential customers online and in person. With this acquisition, we have increased our production capacity by 300%, have added a portfolio of 150+ brands, extensive IP, and a skilled R&D team to create hundreds more products to meet the demand of the burgeoning herbal supplement and CBD markets.”
The U.S. Herbal Supplements Market size was estimated at $2.2 billion in 2021, $2.6 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.62% to reach $4.1 billion by 2027, as forecast by ResearchandMarkets.com. ResearchandMarkets.com’s July 8, 2022 report anticipates the global herbal supplements market will grow from $32.1 billion in 2021 to $49.1 billion by 2027, exhibiting a CAGR of 7.34% during 2021-2027
Research firm Global MarketInsights reports that the Global CBD market in 2021 was $12.8 billion (US portion was $7.7 billion) and is expected to grow at a CAGR of 21.7% to $56.2 Billion by 2028 due primarily to “rising awareness of health benefits of CBD and its effectiveness in pain management and various other treatments.”
“Boulder Botanical is a gem and one of the hidden cornerstones of the health and wellness herbal supplement and CBD industry that has been providing white-label products manufactured to the highest standards to major retailer chains,” noted David Frankens, owner of Frankens Investments. “We jumped at the opportunity to acquire Boulder when it became available because we knew that under the right leadership, the sky would be the limit. We are maintaining a position as strategic equity shareholders in Real Brands. With this acquisition, we believe Real Brands under Thom Kidrin’s leadership, has the capability to capture a dominant position within the CBD industry and be a significant supplier in the health and wellness herbal supplements industry.”
Turning Point Brands, Inc. (NYSE: TPB), is also a long-time strategic investor in Real Brands. Turning Point Brands is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients,
Real Brands has contracted to retain key Boulder Botanical employees for a seamless transition, with no interruption in supply to customers.
Highlights of Boulder Botanical’s capabilities include:
The facility was previously owned by General Electric (GE) and used to manufacture medical devices such as pacemakers. The facility’s infrastructure and construction with Good Manufacturing Practice (GMP) regulations in mind, its safety features, vacuum-sealed rooms, commercial kitchens, and clean rooms are all ideal for producing nutraceutical-grade CBD and herbal supplement products in compliance with certified standards used in the nutraceutical and pharmaceutical industries.
# # #
Contacts:
Media Relations: Accentuate PR, Julie Shepherd 847 275 3643, julie@accentuatepr.com
Sales/Investors: 617-725-8900, info@realbrands.com
About Real Brands Inc.
Real Brands is the result of a 2022 acquisition of Boulder Botanical and Bioscience Laboratories, a herbal supplement and cannabidiol R&D, production and distribution operation producing 150+ brands and supplying white-label products to many of the nation’s largest retailers, and a 2020 merger with Canadian American Standard Hemp Inc. (CASH) that brought together industrial-scale hemp CBD oil/isolate extraction processing and wholesaling, and production and sales of numerous hemp-derived CBD consumer brands of smokable, edible and topical products. Its Halo 5 is a proprietary chromatography extraction technology utilizing a Simulated Moving Bed (SMB) that provides the advantage of producing large quantities of highly purified material and precise pharmaceutical grade molecular separation at dramatically reduced costs.
Visit RealBrands.com and BBBLabs.net.
Consumer product lines are available on https://wabrands.com/, https://phazesports.com/, https://americanstandardhemp.com/, APRA™, and SmartLeef™
We invite you to follow us on social media
LinkedIn: @Real-Brands-Inc
Twitter: @RealBrandsInc
Forward-Looking Statements
This release contains certain forward-looking statements and information relating to Real Brands, Inc. (the “Company”) that are based on the current beliefs of the Company’s management, as well as assumptions made by, and information currently available to, the Company. Such statements reflect the current views of the Company with respect to future events and are subject to certain assumptions, including those described in this release. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as “should,” “could,” “will,” “anticipate,” “believe,” “intend,” “plan,” “might,” “potentially” “targeting” or “expect.” Additional factors that could also cause actual results to differ materially relate to the global COVID-19 crisis, environmental/climate conditions, and other risk factors described in our public filings. The Company does not intend to update these forward-looking statements. The content of the websites referenced above are not incorporated herein.
Attachment